Back
National Cardiovascular Laboratory
Nemzeti Kardiovaszkuláris Laboratórium
Basic data
Field of Operation
Healthy Living
Place of implementation
Budapest, Szeged
Description
With a brand new revolutionary approach, the National Cardiovascular Laboratory aims to explore the pathophysiological mechanism responsible for age-associated cardiovascular disease in order to develop innovative tools for the diagnosis, prevention and therapy of such diseases. Its main professional pillars are clinical - epidemiological programs, innovative drug and biotechnology developments and the development of innovative medical and diagnostic tools and databases.
Main research areas:

  • Clinical-epidemiological programs for the study of ischemic heart disease and heart failure
  • Elucidate the potential medium- and long-term cardiovascular consequences of COVID-19 infection
  • Innovative drug and biotechnology developments
  • New drug targets and repositioning of existing drugs
  • The development of in vitro cardiovascular platforms based on human induced pluripotent stem cells
  • Innovative medical and diagnostic tools and databases
  • Biomarkers and measurement methods for extracellular vesicle-based diagnostic and therapeutic approaches

Benefits to be expected from laboratory research:

  • The research results of the National Cardiovascular Laboratory will represent a decisive contribution to the development of evidence-based cardiovascular health promotion and disease prevention programs, helping to achieve the goal of living a longer and healthy life for the population of the country.
  • The interdisciplinary and translational nature of the program ensures that it successfully implements the development of evidence-based innovative disease prevention, screening, diagnostic and therapeutic procedures to reduce the incidence and mortality of cardiovascular diseases and supports their translation into medical and public health practice.
  • The results of the program contribute to the access to international markets for innovative high economic value-added products and services, thus helping the development of the domestic pharmaceutical biotechnology industry.


Consortium leader

Semmelweis University


Consortium partners

  • Neumann Medical Ltd.
  • Pharmahungary 2000 Ltd.
  • University of Szeged
  • 3DHISTECH Ltd.


Contact

E-mail:
nkl@semmelweis-univ.hu

Webpage:
semmelweis.hu/innovacio/nemzeti-laboratoriumok/nkl/

Utolsó módosítás: 15 December 2022
Download files


National Cardiovascular Laboratory
(pdf, 5978 KB)
Previous Laboratory
Molecular Fingerprinting National Laboratory
23 February 2022
Next Laboratory
National Laboratory for Autonomous Systems
23 February 2022
Related news
News and Press
News
Video - How do Horizon Results Booster Services help?

A hazai kutatók nemzetközi beágyazottságát, kutatás-fejlesztési együttműködéseit nagymértékben elősegíti aktív kapcsolatuk a világ legjelentősebb kutatási infrastruktúráival (KI) és bekapcsolódásuk az ott folyó élvonalbeli kutatásokba. A legkorszerűbb KI-k olyan nagy költségű berendezések, létesítmények vagy adatbankok, amelyek építése, fejlesztése és működtetése meghaladja egy-egy ország gazdasági teljesítőképességét, így nemzetközi együttműködésben valósulnak meg.

18 02 2022
Read more
News
Ministry for Innovation and Technology: Government supports cutting-edge health innovations and the start of a researcher career
Budapest, Saturday, 9 April 2022 (MTI) - According to recent government decisions, a total of ten billion forints will be used in world-class research and development projects and the Cooperative Doctoral Programme, the Ministry for Innovation and Technology (ITM) told MTI on Saturday.
09 04 2022
Read more
News
University technologies showcased at the Innovation Partnering Day of the University of Pécs
Vice President Katalin Sebők spoke about the functioning, benefits and role of Regional Innovation Platforms in building the innovation ecosystem at the event showcasing university technologies.
28 03 2022
Read more